• Lap-Band

    lapband logo

    The LAP-BAND® Adjustable Gastric Banding System.
    A healthy, lasting, weight loss solution.

    For Patients
  • Lap-Band

    lapband logo

    The LAP-BAND® Adjustable Gastric Banding System. A healthy, lasting, weight loss solution.

    For Patients

Significant Long Term Weight Loss

The LAP-BAND® System, a minimally invasive procedure that offers significant and long-lasting weight loss, is the first adjustable medical device approved by the U.S. Food and Drug Administration (FDA) for individualized weight loss for obese patients1 (BMI varies by country) with an obesity-related comorbidity.** The system is fully adjustable, allowing you to help patients meet their long-term weight loss goals through a less invasive laparoscopic approach.

In a recent study1, patients with the LAP-BAND® System showed an average of 65% excess weight lost at 1 year1. The study also showed a significant improvement in co-morbidities.

For more information, please visit www.lapband.com

Lap-band - Product Info

Product Highlights

  • First and only FDA-approved device for weight loss surgery in patients with a BMI of 30-40** with an obesity-related comorbidity**
  • Designed for long-term use, but with the ability to be reversed or removed if desired
  • The LAP-BAND® has shown to improve or resolve obesity related comorbidities such as diabetes, hypertension and sleep apnea1 **
  • Adjustable to fit the needs of the patient
  • Does not require stapling of the stomach or stomach amputation
  • The LAP-BAND® comes in two sizes and several*** port options
  • Over 860,000 LAP-BAND® Systems have been placed worldwide

Important LAP-BAND® System Safety Information

Indications: The LAP-BAND® System is indicated for weight reduction for patients with obesity; see DFUs for specific indicators. It is indicated for use only in patients** who have failed more conservative weight reduction alternatives, such as supervised diet, exercise and behavior modification programs. Patients who elect to have this surgery must make the commitment to accept significant changes in their eating habits for the rest of their lives.

Contraindications: The LAP-BAND® System is not recommended for patients** with conditions that may make them poor surgical candidates or increase the risk of poor results (e.g., inflammatory or cardiopulmonary diseases, GI conditions, symptoms or family history of autoimmune disease, cirrhosis), who are unwilling or unable to comply with the required dietary restrictions, who have alcohol or drug addictions, or who currently are or may be pregnant.

Warnings: The LAP-BAND® System is a long-term implant. Explant and replacement surgery may be required. Patients who become pregnant or severely ill, or who require more extensive nutrition may require deflation of their bands. Anti-inflammatory agents, such as aspirin, should be used with caution and may contribute to an increased risk of band erosion.

Adverse Events: Placement of the LAP-BAND® System is major surgery and, as with any surgery, death can occur. Possible complications include the risks associated with the medications and methods used during surgery, the risks associated with any surgical procedure, and the patient’s ability to tolerate a foreign object implanted in the body. Band slippage, erosion and deflation, reflux, obstruction of the stomach, dilation of the esophagus, infection, or nausea and vomiting may occur. Reoperation may be required. Rapid weight loss may result in complications that may require additional surgery. Deflation of the band may alleviate excessively rapid weight loss or esophageal dilation.

Important: For full safety information please click here, talk with your doctor, or call Apollo Customer Support at 1-855-551-3123.

CAUTION: Rx only.

1. Robert Michelson, Diane K. Murphy, Todd M. Gross, and Scott M. Whitcup. LAP-BAND® for Lower BMI: 2-Year results from the Multicenter Pivotal Study. Obesity (2013) 21: 1148-1158.

**See specific regional information for indicated BMI range and indications.

***Access port availability varies by market.